S-1 may be active in oral squamous cell cancer

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1623, 2008-01, pp. : 13-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adalimumab/etanercept/infliximab: Oral squamous cell cancer: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1318, 2010-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Inhibitory Growth of Oral Squamous Cell Carcinoma Cancer via Bacterial Prodigiosin

By Cheng Ming-Fang   Lin Chun-Shu   Chen Yu-Hsin   Sung Ping-Jyun   Lin Shian-Ren   Tong Yi-Wen   Weng Ching-Feng  

Marine Drugs, Vol. 15, Iss. 7, 2017-07 ,pp. : 224-224

MDPI

Access to resources Recommend Favorite

Paclitaxel in combination with cisplatin is "active and promising" in advanced squamous cell oesophageal cancer

By  

Inpharma, Vol. 1, Iss. 1629, 2008-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Antineoplastics: Squamous cell cancer (first report with doxorubicin, tamoxifen and fluorouracil) of the oral cavity: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1130, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

H+-myo-Inositol Transporter SLC2A13 as a Potential Marker for Cancer Stem Cells in an Oral Squamous Cell Carcinoma

By  

Current Cancer Drug Targets, Vol. 11, Iss. 8, 2011-10 ,pp. : 966-975

Bentham Science Publishers

Access to resources Recommend Favorite